Psoriasis is a chronic autoimmune dermatologic condition characterised by red, itchy patches with whitish scaling of the skin. If you suffer from mild, moderate, or severe psoriasis, you may be eligible for participating in a current or upcoming clinical trial. Please contact us to check eligibility and/or to register your interest.
Trial for 18+ with moderate to severe plaque-type psoriasis
Participants: Aged 18 years or older with severe plaque-type psoriasis
Drug Type and Administration: Guselkumab by injection
Status: Active. Registrations Currently Closed.
Additional information: A Study of Moderate to Severe Plaque-Type Psoriasis by ClinicalTrials.gov
Trial for 18+ with mild to moderate plaque-type psoriasis
Participants: Aged 18 years or older with mild to moderate plaque-type psoriasis
Drug Type and Administration: AKP-11 (topical ointment)
Additional Information: A Study of Plaque-Type Psoriasis by ANZCTR
Fill in your details below to register your interest. Our Clinical Trials Coordinator will be in touch shortly to discuss your eligibility for the trial you have selected.
Alternatively, ring us on 02 8279 2739 to speak to our clinical trials specialist today or Email email@example.com